Facebook
Twitter
LinkedIn
ForwardBuilding a Primary Palliative Care Model for Urology (2021)
Live Webinar 1: Building a Primary Palliative Care Model for Urology
Complimentary CME Webinar!
Saturday, May 15, 2021 | 10:00 a.m. - 12:00 p.m. EDT
Building a Primary Palliative Care Model for Urology: learn about aspects of palliative care that benefit patients, the urologist’s role and their collaboration with palliative care clinicians including:
The current state of palliative care:
- Evidence for subspecialty-based primary palliative care
- Aspects of palliative care that most benefit patients
- Patient perspective – how doctors can best support patients at the end of life
- Delivery of palliative care services in Urology
When palliative care is needed:
- Panel discussion on identifying the continuum of care, timing, and the extent to which palliative care clinicians should be involved, with emphasis on oncology, stone disease, and female pelvic medicine and reconstructive surgery.
Target Audience
- Urologist
- Resident
- Non-Urologist (MD or DO)
- Nurse Practitioner
- Physician Assistant
- Practice Manager
Learning Objectives
At the conclusion of Building a Primary Palliative Care Model for Urology participants will be able to:
- Identify the optimal timing, provider, and support required to support the needs of patients with advanced urologic disease
- Describe the settings in which goals of care, prognosis, diagnosis, advance care planning, goals of operations and procedures, and physical and psychological symptom management are currently being pursued.
- Explain methods of family engagement that support both the family and the patient as disease progresses.
- Discuss aspects of patient care and counseling that are lacking within current health systems.
- Assess the spiritual and support needs among patients with advanced urologic health conditions, and the point along the disease course when this support should be offered.
The 2021 AUA Quality Improvement Summit is a three-part program designed for the entire urologic care team aimed at improving the use of palliative care in urology. Educational activities will feature presentations, panel discussions, and opportunities to share experience and data to improve care quality using palliative care. Building a Primary Palliative Care Model for Urology is the first webinar of the three-part series.
Please join us on May 22, 2021 from 1 pm-2:30pm EDT for Webinar 2: Perspectives on Increasing the Use of Palliative Care in Advanced Urologic Diseases. Discover evidence-based innovations in primary palliative care in urology, and explore role-specific readiness for implementation.
This second webinar is a part of the AUA2021 Annual Meeting Kickoff Weekend. Attendees must be registered at the Platinum, Gold, Silver or Bronze package to access this education.
Please join us on September 13, 2021 from 8am-11am PDT for the in-person portion of the Quality Improvement Summit: Laying the Foundation for Primary Palliative Care in Urology at the AUA 2021 Annual Meeting in Las Vegas.
The in-person program will include didactic presentations, panel discussions, small-group breakout sessions, and a final full-group interactive discussion. Attendees would benefit from attending the two QI Summit webinars and must be registered for the AUA2021 Annual Meeting to attend the in-person session.
Learn more about the QI Summit programming at AUAnet.org/QISummit. To register, visit AUA2021 and select the Platinum Registration option and add the QI Summit to your schedule.
Current State of Palliative Care:
Moderator Matthew Nielsen, MD, MS, Chair, AUA Quality Improvement and Patient Safety Committee
- Evidence for Subspecialty-based Primary Palliative Care: Katherine Fero, MD
- Aspects of Palliative Care That Most Benefit Patients: Karl Lorenz, MD, MSHS
- Patient Perspective – How Doctors Can Best Support Patients at the End of Life: Renata Louwers
- Delivery of Palliative Care Services in Urology: Jonathan Bergman, MD, MSHS
When is Palliative Care Needed? Panel discussion on identifying the continuum of care, timing, and extent to which palliative care clinicians should be involved:
Moderator Jonathan Bergman, MD, MSHS
- Oncology: Scott Gilbert, MD, MS, Bruce Jacobs, MD
- Stone Disease: Margaret Pearle, MD; John Leppert, MD, MS; Charles Scales, MD, MS
- Female Pelvic Medicine and Reconstructive Surgery: Anne Suskind, MD, MS
- General Urology: Michael Darson, MD
COI Review Work Group Disclosures
COI Review Work Group Disclosures 2021
All relevant disclosures for planners and faculty have been mitigated.
Jonathan Bergman, MD
John Gore, MD
Matthew Nielsen, MD
Micheal Darson, MD
Katherine Fero, MD
Scott Gilbert
Bruce Jacobs, MD, MPH
John Leppert, MD, MS
Margaret Pearle, MD, PHD
Charles Scales, MD
Anne Suskind, MD
Emily Calvert, RN
Karen Johnson,
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
MITIGATION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:
- Peer review for valid, evidence‐based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point‐counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only
- in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off‐label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA Participant Information and Policies
AUA ANTI-HARRASSMENT POLICY:
AUA Commitment: AUA is committed to providing a safe and productive meeting environment that fosters open dialogue and the exchange of scientific ideas and is free of harassment and discrimination. All meeting participants are expected to behave professionally and treat others with respect, follow venue rules, and alert AUA staff or security of any dangerous situations or anyone in distress.
Reporting Harassment: It is the policy of the AUA that all meeting participants will enjoy an environment free from discrimination, harassment or retaliation. Harassing or offensive behavior by meeting participants will not be tolerated. If an individual experiences or witnesses harassment, he or she should contact Janet Skorepa, AUA EVP, at jskorepa@AUAnet.org or Diane Bieri, AUA General Counsel, at dbieri@AUAnet.org or use a venue phone and ask for security if he or she feels unsafe. All complaints will be treated seriously and responded to promptly.
The AUA reserves the right to take any action deemed necessary and appropriate, including refusing or revoking the registration of any individual, without refund, as long as such refusal is consistent with applicable law and AUA policy.
DISCLAIMER:
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:
The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.
REPRODUCTION PERMISSION:
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Non-Physician Participation
Registration is complimentary.
To register for the webinar:
- Click on the TAKE COURSE button.
- Click “Start” under "Live Webinar" in the Course Progress pane.
- Click on the link provided to register in advance for this webinar.
- After registering, you will receive a confirmation email containing information about joining the webinar.